CClinicalTrials.gg
Enrolling by invitationNCT06472817Updated Sep 28, 2026

Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

An observational study in Prostate Carcinoma, sponsored by Mayo Clinic. Enrolling by invitation at 2 sites in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by Mayo Clinic · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
80
Ages
18 Years and older
Sex
Male
01

Study summary

This study is being done to understand what social factors affect health decisions for those who have immigrated from another country by examining how the immigration from Sub-Sahara Africa affects the experiences of participants regarding health-seeking behaviors, care, and treatment of prostate cancer. It also examines similarities and differences among participants based on their region of origin in Africa.

Read the detailed description

PRIMARY OBJECTIVE:

I. To employ the social determinant of migrant health framework (International Organization for Migration, n.d.) to examine the impact of immigration on the health-seeking behaviors of SSAI including informed-decision making, psychosocial effects and coping mechanisms. (Phase I) II. To examine SDOMH factors among SSAI and CI men, including their migration experience and health behaviors. (Phase II)

OUTLINE: This is an observational study.

AIM I: Participants complete a survey and participate in an interview in person, over the phone, or via zoom on study.

AIM II: Participants complete an interview in person, over the phone, or via zoom on study.

02

Conditions studied

  • Prostate Carcinoma

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Sub-Saharan African immigrant men who were diagnosed with prostate cancer.

Inclusion criteria

  • PHASE I:

    • Adult men originally from each of these geographic regions (East, West, Central, and Southern Africa) and have been diagnosed with prostate cancer
    • Able to provide written consent and conduct an interview
    • Able to speak and understand English
  • PHASE II:

    • Caribbean Immigrant men and SSAI men diagnosed with CaP within the last 10 years who identify as Black and speak English
    • Able to provide written consent and conduct an interview
    • Able to speak and understand English

Exclusion criteria

Exclusion Criteria:

  • PHASE I:

    • Patients below the ages of 18, and those not belonging to any of four regions
    • Employees of Mayo Clinic will be excluded
    • Non-English speakers will not be included
  • PHASE II:

    • Individuals below the age of 18
    • Those not diagnosed with prostate cancer and individuals not from the regions described above
    • Employees of Mayo Clinic will be excluded
    • Non-English speakers will not be included
04

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
80 participants (estimated)

Groups and cohorts

  • Observational

    AIM I: Participants complete a survey and participate in an interview in person, over the phone, or via zoom on study. AIM II: Participants complete an interview in person, over the phone, or via zoom on study.

    Other: Non-Interventional Study

Interventions

  • OtherNon-Interventional Study

    Non-interventional study

05

What researchers measure

Primary outcomes

  1. Qualitative Interview - identification of themes and constructs

    Data will be collected during an in-depth interview and will be analyzed with an inductive, open coding approach, first identifying themes, then constructs that emerge from the data will be categorized and mapped, noting new concepts and constructs. Theme convergence and divergence will be assessed. The interview guide focuses on participants' experiences and health-seeking behaviors regarding prostate cancer prevention, detection, decision-making, treatment, care, and survivorship.

    Time frame: Baseline

  2. Immigrant social determinants of health factors that impact Sub-Saharan African Immigrant (SSAI) carcinoma of the prostate (CaP) survivors

    From the data generated in Outcome 1 interviews, an interpretive framework or theoretical model for SSAI men will be developed to evaluate and identify factors that contribute to or exacerbate disparities in prostate cancer.

    Time frame: Baseline

06

Study locations

2 sites
  • Georgia State University
    Atlanta, Georgia 30302-3965, United States
  • Mayo Clinic in Rochester
    Rochester, Minnesota 55905, United States
07

References and documents

08

Registry details

Key details

Study ID
NCT06472817
Lead sponsor
Mayo Clinic
Collaborators
Congressionally Directed Medical Research Programs
Responsible party
Sponsor
First posted
Jun 25, 2024
Start date
Sep 5, 2023
Primary completion
Sep 29, 2028 (estimated)
Completion
Sep 29, 2028 (estimated)
Last update
Sep 28, 2026

Study contacts

Gladys B. Asiedu, Ph.D.
principal investigator · Mayo Clinic in Rochester

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion